| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6199352 | Ophthalmology | 2015 | 13 Pages |
Abstract
In CATT, the B50 group had a visual prognosis similar to the Other group. Lesion size decreased markedly through 2 years. Eyes like those enrolled in CATT with neovascular AMD lesions composed of >50% blood can be managed similarly to those with less or no blood.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Michael M. MD, Ebenezer MBBS, PhD, Daniel F. MD, Robert A. MD, Juan E. MD, Michael M. MD, PhD, Alexander MD, MA, Lawrence S. MD, PhD, Jiayan MS, Frederick L. MD, Stuart L. MD, Maureen G. PhD,